Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
Клиническая характеристика 138 госпитализированных пациентов с пневмонией, вызванной новым коронавирусом 2019 года, в Ухане, Китай
2020-02-07
SCID: 54.1/hwtzphy4
Discuss with AI
Antiviral therapyCOVID-19 pneumoniaGround-glass opacityHospital-associated transmissionLymphopenia
Figures from the paper
Abstract (AI)
Importance: In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited. Objective: To describe the epidemiological and clinical characteristics of NCIP. Design, Setting, and Participants: Retrospective, single-center case series of the 138 consecutive hospitalized patients with confirmed NCIP at Zhongnan Hospital of Wuhan University in Wuhan, China, from January 1 to January 28, 2020; final date of follow-up was February 3, 2020. Exposures: Documented NCIP. Main Outcomes and Measures: Epidemiological, demographic, clinical, laboratory, radiological, and treatment data were collected and analyzed. Outcomes of critically ill patients and noncritically ill patients were compared. Presumed hospital-related transmission was suspected if a cluster of health professionals or hospitalized patients in the same wards became infected and a possible source of infection could be tracked. Results: Of 138 hospitalized patients with NCIP, the median age was 56 years (interquartile range, 42-68; range, 22-92 years) and 75 (54.3%) were men. Hospital-associated transmission was suspected as the presumed mechanism of infection for affected health professionals (40 [29%]) and hospitalized patients (17 [12.3%]). Common symptoms included fever (136 [98.6%]), fatigue (96 [69.6%]), and dry cough (82 [59.4%]). Lymphopenia (lymphocyte count, 0.8 × 109/L [interquartile range {IQR}, 0.6-1.1]) occurred in 97 patients (70.3%), prolonged prothrombin time (13.0 seconds [IQR, 12.3-13.7]) in 80 patients (58%), and elevated lactate dehydrogenase (261 U/L [IQR, 182-403]) in 55 patients (39.9%). Chest computed tomographic scans showed bilateral patchy shadows or ground glass opacity in the lungs of all patients. Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]). Thirty-six patients (26.1%) were transferred to the intensive care unit (ICU) because of complications, including acute respiratory distress syndrome (22 [61.1%]), arrhythmia (16 [44.4%]), and shock (11 [30.6%]). The median time from first symptom to dyspnea was 5.0 days, to hospital admission was 7.0 days, and to ARDS was 8.0 days. Patients treated in the ICU (n = 36), compared with patients not treated in the ICU (n = 102), were older (median age, 66 years vs 51 years), were more likely to have underlying comorbidities (26 [72.2%] vs 38 [37.3%]), and were more likely to have dyspnea (23 [63.9%] vs 20 [19.6%]), and anorexia (24 [66.7%] vs 31 [30.4%]). Of the 36 cases in the ICU, 4 (11.1%) received high-flow oxygen therapy, 15 (41.7%) received noninvasive ventilation, and 17 (47.2%) received invasive ventilation (4 were switched to extracorporeal membrane oxygenation). As of February 3, 47 patients (34.1%) were discharged and 6 died (overall mortality, 4.3%), but the remaining patients are still hospitalized. Among those discharged alive (n = 47), the median hospital stay was 10 days (IQR, 7.0-14.0). Conclusions and Relevance: In this single-center case series of 138 hospitalized patients with confirmed NCIP in Wuhan, China, presumed hospital-related transmission of 2019-nCoV was suspected in 41% of patients, 26% of patients received ICU care, and mortality was 4.3%.
Key Findings
1
Chest CT scans showed bilateral patchy shadows or ground-glass opacities in the lungs of all patients.
2
Hospital-associated transmission was suspected among 40 health professionals (29%) and 17 hospitalized patients (12.3%).
3
Most patients received antiviral therapy with oseltamivir (89.9%), while 64.5% received moxifloxacin antibacterial therapy.
4
The predominant symptoms were fever (98.6%), fatigue (69.6%), and dry cough (59.4%); lymphopenia occurred in 70.3% of patients.
5
This retrospective case series characterized 138 hospitalized patients with confirmed 2019-nCoV-infected pneumonia in Wuhan between January 1 and January 28, 2020.
Research Object
138 hospitalized patients with 2019-nCoV–infected pneumonia (NCIP) at Zhongnan Hospital of Wuhan University
Research Subject
The epidemiological and clinical characteristics of NCIP, including symptoms, laboratory and radiological findings, treatments, outcomes, and presumed hospital-associated transmission
Publication Details
Publication Date
2020-02-07
Journal
Publisher
ISSN
Cited by
21057
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by20
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China2020
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status2020
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study2020
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study2020
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients2020
A first case of meningitis/encephalitis associated with SARS-Coronavirus-22020
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission2020
Risk factors for severe and critically ill COVID‐19 patients: A review2020
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-192020
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐192020
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies2023
COVID-19 pandemic: A review of the global lockdown and its far-reaching effects2021
The COVID-19 pandemic and physical activity2020
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus2022
Stroke in COVID-19: A systematic review and meta-analysis2020
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis2021
Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment2020
Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic2020
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside2020
Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-192020